Amgen gets US approval to treat immunoglobulin G4-related disease
HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and
Drugs
Health
Medical
Climate
Health
Medical
Africa’s health sector facing ‘unprecedented’ financial crisis: CDC
HQ Team April 4, 2025: Africa’s health sector faces an ‘unprecedented’ financing crisis, driven by a sharp fall of 70% in official development
Drugs
Health
Medical
Aldeyra Therapeutics’ dry eye treatment rejected by USFDA
HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating
Drugs
Health
Pharma
Siemens AG to acquire US-based Dotmatics for $5.1 billion
HQ Team April 3, 2025: Siemens AG will acquire US, Boston-based Dotmatics for $5.1 billion from Insight Partners to expand its digital life
Drugs
Health
Pharma
Bavarian Nordic gets FDA nod for free-dried smallpox, mpox vaccine
HQ Team April 2, 2025: Denmark’s Bavarian Nordic A/S has got approval from the US Food and Drug Administration for its freeze-dried formulation
Drugs
Health
Medical
Sudan heading for famine as fighting ravages Darfur, UN warns
HQ Team April 2, 2025: Sudan’s humanitarian crisis and security situation remain “dire and worsening,” with a famine looming on the horizon, according
Drugs
Medical
Pharma
Organon & Co. buys biosimilar from Biogen for an undisclosed sum
HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from
Climate
Health
Research
New AI-driven weather system to deliver forecasts ten times faster
HQ Team April 1, 2025: Aardvark Weather, an artificial intelligence weather predicting system, can deliver accurate forecasts tens of times faster and using
Climate
Drugs
Health
Cholera claims lives of 329 people in Angola, WHO says spread risk is ‘high’
HQ Team April 1, 2025: Three-hundred and twenty-nine people died after being infected with cholera in the West African nation of Angola as
Drugs
Health
Pharma
AstraZeneca’s mantle cell cancer drug gets body’s nod for EU approval
HQ Team April 1, 2025: AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union